José Antonio de la Puente

José Antonio joined Alcaliber in 2004 as Managing Director, having served as Secretary of the Board of Directors since 1999. From 2018 to 2021, he also held the role of CEO at Linneo Health, the first company in Spain licensed to cultivate and sell pharmaceutical cannabis.

With over 20 years of experience in the pharmaceutical industry, José Antonio has navigated the transition from a Family Office to a Private Equity environment. Prior to his time at Alcaliber, he held several key positions at Torreal, Alcaliber’s former parent company, including Head of Legal and Tax and member of the Board of Directors for various portfolio companies.

He holds a law degree and a Master’s in Business Law, supplemented by ongoing education in business and finance.